Sign in
4

Changes in Ownership

Bausch Health Companies Inc. Filed Acc 0001127602-22-005469

U.S. President-Pharma Business sold 3,251 shares at $25.02 ($81,340)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Spurr Robert U.S. President-Pharma Business 2022-02-15 Sale −3,251 $25.02 $81,340 60,299 D
Open-market sales · 3,251 sh · avg $25.02 · $81,340
Loading xslF345X03/form4.xml…